(Q46135566)

English

Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment

scientific article published on 3 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment (English)

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

1 reference

based on heuristic

inferred from title

Teresa Ramón Y Cajal

1

object named as

T Ramón y Cajal

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

author name string

A Altés

2

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

L Paré

3

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

E del Rio

4

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

C Alonso

5

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

A Barnadas

6

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

M Baiget

7

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

language of work or name

0 references

publication date

3 February 2009

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

119

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

33-38

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

1

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

https://scigraph.springernature.com/pub.10.1007/s10549-009-0328-y

0 references

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

1 reference

https://api.crossref.org/works/10.1007%2FS10549-009-0328-Y

21 January 2018

Identifiers

10.1007/S10549-009-0328-Y

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

1 reference

Europe PubMed Central

19 December 2017

http://europepmc.org/abstract/MED/19189210

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46135566&oldid=2094190853"